Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon | Zendy

Jacques Mokhbat | Zendy; Nada M. Melhem | Zendy; Ziad ElKhatib | Zendy; Pierre Zalloua | Zendy

Open Access

Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon

Author(s) -

Jacques Mokhbat,

Nada M. Melhem,

Ziad ElKhatib,

Pierre Zalloua

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.3593

Subject(s) - antiretroviral drug , virology , human immunodeficiency virus (hiv) , drug resistance , medicine , drug naïve , antiretroviral therapy , drug , immunology , viral load , biology , pharmacology , microbiology and biotechnology

Antiretroviral therapy (ART) has been successful at decreasing the morbidity and mortality associated with human immunodeficiency virus type 1 (HIV-1) infection. HIV-1 drug resistance (HIVDR) among ART-naive patients has been documented to compromise the success of initial therapy. This study was conducted to determine the prevalence of HIVDR mutations among newly diagnosed drug-naive HIV-infected individuals in Lebanon.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research